EUCTR2012-000363-24-NL进行中（未招募）1 期
The effect of dipyridamole on the pharmacokinetics of metformin. - Met-Dipy interaction trial.
Radboud University Medical Centre Nijmegen0 个研究点目标入组 18 人开始时间: 2012年2月22日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 18
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- Age 18-50 years
- •- Written informed consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 18
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- Hypertension (systolic blood pressure >140 mmHg and/or diastolic blood pressure >90 mmHg)
- •- Diabetes Mellitus (fasting glucose >7 mmol/L or random glucose >11 mmol/L)
- •- History of any cardiovascular disease
- •- Renal dysfunction (MDRD <60 ml/min)
- •- ECG abnormalities, other than first grade AV-block or right bundle branch block
研究者
相似试验
招募中
4 期
The effect of dipyridamole on the pharmacokinetics of metformin.geneesmiddeleninteractieDrug interactionNL-OMON37582niversitair Medisch Centrum Sint Radboud18
已完成
不适用
The effects of oral dipyridamole treatment on the innate immune response during human endotoxemia.Blood poisoning1000401810011954sepsisNL-OMON34679niversitair Medisch Centrum Sint Radboud30
尚未招募
4 期
Does short dipyridamole administration induce protection against ischemia-reperfusion injury?infarctionischemia reperfusion injury1001108210003216NL-OMON31190niversitair Medisch Centrum Sint Radboud10
进行中（未招募）
1 期
Comparison between Dipyridamole and Adenosine infusion in the evaluation of intermediate coronary restrictions (stenoses) in the cardiac catheterization laboratorY.Patients with a single = 50% e <75% coronary stenosis (visually extimated) at angiography, in one ore more coronary vessels).EUCTR2010-024485-21-ITFONDAZIONE TOSCANA GABRIELE MONASTERIO75
已完成
4 期
Pharmacokinetics of Dipyridamole Administered as Aggrenox® (Dipyridamole Extended Release Plus Aspirin) Capsule Versus Dipyridamole Immediate Release Plus Aspirin Following Alteration of Stomach pHHealthyNCT02251184Boehringer Ingelheim31